期刊文献+

荷瘤小鼠外周血髓系抑制性细胞的比例与血清转化生长因子-β_1水平的关系 被引量:2

Correlation between percentage count of peripheral myeloid -derived suppressor cells and serum level of TGF-β_1 in tumor bearing mice
下载PDF
导出
摘要 目的通过建立小鼠原位肝癌模型,检测荷瘤小鼠外周血髓系抑制性细胞(MDSC)的比例和血清转化生长因子(TGF)-β1水平,探讨其在肝癌发病中的作用机制。方法建立小鼠原位肝癌模型,分离荷瘤小鼠外周血的单个核细胞,流式细胞仪检测荷瘤小鼠不同时间外周血MDSC的比例;酶联免疫吸附试验(ELISA)检测荷瘤小鼠血清TGF-β1水平。以同期正常小鼠作对照。结果荷瘤小鼠外周血MDSC比例明显升高:对照组、模型组7、14、21d外周血MDSC的比例分别为(3.5±2.2)%、(9.4±2.6)%、(16.4±5.6)%、(25.3±11.3)%,除模型组7d与对照组比较差异无统计学意义(P>0.05)外,其余各组与对照组比较均有统计学意义(P<0.05);荷瘤小鼠血清TGF-β1水平明显升高:对照组、模型组7、14、21d血清TGF-β1水平分别为(4.9±1.4)、(14.1±6.0)、(24.0±3.3)、(9.2±1.2)ng/ml。除模型组21d与对照组比较差异无统计学意义(P>0.05)外,其余各组与对照组比较差异均有统计学意义(P<0.05)。外周血MDSC的比例与血清TGF-β1水平呈明显正相关(r=0.564,P<0.05)。结论随着肿瘤的进展,外周血MDSC的比例明显升高,且与血清TGF-β1水平呈明显正相关,提示荷瘤小鼠外周血MDSC的比例与肿瘤的生长进展密切相关,MDSC通过分泌TGF-β1发挥免疫抑制作用,可促进肿瘤的生长与转移。 Objective To investigate the correlation between percentage count of peripheral myeloid-derived suppressor ceils (MDSC) and serum level of transforming growth factor beta 1 (TGF-β1) in entopic hepatocarcinoma mouse model, and to explore the role of MDSC in pathogenesis of liver cancer. Methods Mouse model of entopic liver cancer was established. Peripheral mononuclear cells (PMNCs) were separated from the tumor-bearing mice. At various time points, the percentage of MDSC in PMNCs was analyzed by flow cytometry, the level of serum TGF-β1 were tested by enzyme-linked immunosorbent assay, and these were compared with healthy mice as controls. Results The percentage of MDSC in peripheral blood and the level of serum TGF-β1 were significantly higher than those in control group. On days 7, 14 and 21, the percentages of MDSCs in PMNCs were (3.5±2.2)%, (9.4±2.6)%, (16.4±5.6)% and (25.3±11.3)%. These figures were statistically significant as compared with the controls (P〈0.05) except for on day 7 (P〉0.05). On days 7, 14 and 21, the serum level of TGF-β1 were (14.1±6.0), (24.0±3.3) and (9.2±1.2)ng/ml. These figures were statistically significant as compared with the controls [(4.9±1.4)ng/ml, (P〈0.05)] except for on day 21 (P〉 0.05). There was a significantly positive correlation between MDSC in peripheral blood and serum level of TGF-β1 (r= 0.564, P〈0.05). Conclusion Along with tumor progression, the percentage of MDSC in PMNCs increased and was positively correlated with serum level of TGF-β1, suggesting a close relationship between percentage count of MDSC and tumor growth, MDSC may promote tumor growth and metastasis through secretion of immunosuppressing TGF-β1.
出处 《中国药物与临床》 CAS 2010年第3期274-276,共3页 Chinese Remedies & Clinics
关键词 肝细胞 转化生长因子B 髓系抑制性细胞 免疫抑制 Carcinoma,hepatocellular Transforming growth factor beta Myeloid-derived suppressor ceils Immunosuppression
  • 相关文献

参考文献10

  • 1Rodriguez PC,Hernandez CP,Quiceno D,et al. Arginase Ⅰ in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med, 2005,202:931-939.
  • 2姜晗昉,任军,崔勇,张晓鹏.小鼠原位移植性肝癌模型的建立及其磁共振表现[J].现代肿瘤医学,2007,15(2):174-176. 被引量:6
  • 3Bronte V,Apolloni E,Cabrelle A, et al. Identification of a CD11b^+/ Gr-Ⅰ^+/CD31^+ myeloid progenitor capable of activating or suppressing CD8^+T cells. Blood,2000,96:3838-3846.
  • 4Capuano G, Rigamonti N,Grioni M,et al. Modulators of arginine metabolism support cancer immunosurveillance. BMC Immunol, 2009, 10:1-36.
  • 5Li HQ,Han YM,Guo QL,et al. Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol, 2009,182 ( 1 ):240-249.
  • 6Ochoa AC,Zea AH,Hernandez C et al. Arginase,prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma. Clin Cancer Res,2007,13(2 Pt 2):721s-726s.
  • 7Serafini P,Borrello I,Bronte V. Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol,2006,16:53-65.
  • 8Yang L,Debusk LM,Fukuda K,et al. Expansion of anyeloid immune suppressor Gr1CD11b cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell, 2004,6:409-421.
  • 9Eiji S,Veena K, Arminder SJ,et al. Gemcitabine selectively eliminates splenic Gr-1^+/CD11b^+ myeloid suppressor cells in tumorbearing animals and enhances antitumor immune activity. Clin Cancer Res, 2005,11 (18) :6713-6721.
  • 10王芙蓉,李云霞.转化生长因子β_1与肿瘤关系的研究进展[J].医学综述,2008,14(9):1318-1320. 被引量:7

二级参考文献24

  • 1韩克起,顾伟,胡侠,张亚妮,黄雪强,刘岭,苏永华,凌昌全.小鼠肝癌原位移植模型的建立及生物学特性[J].中西医结合学报,2004,2(5):372-374. 被引量:23
  • 2李海燕,方肇勤,梁尚华.小鼠移植性肝癌(H_(22))模型的研究及在中医药抗肿瘤中的应用[J].中国中医基础医学杂志,2000,6(1):27-30. 被引量:31
  • 3王锦波,吕毅,潘承恩,王居,刘青光.W256大鼠肝癌模型的制作及传代保存[J].肝胆外科杂志,1995,3(2):121-122. 被引量:21
  • 4崔澂,王润田.TGF-β介导的肿瘤免疫抑制研究及临床意义[J].实用肿瘤杂志,2005,20(5):457-460. 被引量:5
  • 5Iwanuma Y,Chen F,Egilmez N,et al.Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice[J].Cancer Res,1997,57 (14):2937 ~ 2942.
  • 6Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics 2002[J].CA Cancer J Clin,2005,55:74 ~ 108.
  • 7Djaborkhel R,Tvrdik D, Eckschlager T, et al. Cyclin A downregulation in TGF-betal arrested follicular lymphoma cells [ J ]. Exp Cell Res,2000,261 ( 1 ) :250-259.
  • 8Shariat SF, Kim JH, Andrews B, et al. Preoperative plasma levels of transforming growth factor beta ( 1 ) strongly predict clinical outcome in patients with bladder carcinoma [ J ]. Cancer, 2001,92 (12) :2985-2992.
  • 9Inman G, Allday MJ. Resistance to TGF-betal correlates with areduction of TGF-beta type Ⅱ receptor expression in burkitts lymphoma and epstein-Barr virus transformed B lympboblastoid cell lines[ J]. J General Virol,2000,81 ( Pt 6) : 1567-1578.
  • 10Seijo ER, Song H, Lynch MA, et al. Identification of genetic alterations in the TGF-beta type Ⅱ receptor gene promoter [ J ]. Mutat Res,2002,483(1-2) : 19-26.

共引文献11

同被引文献17

  • 1姜晗昉,任军,崔勇,张晓鹏.小鼠原位移植性肝癌模型的建立及其磁共振表现[J].现代肿瘤医学,2007,15(2):174-176. 被引量:6
  • 2曹雪涛.肿瘤生长与转移中的免疫学问题[J].中国肿瘤生物治疗杂志,2007,14(1):2-6. 被引量:23
  • 3刘俊林,李汉贤.一氧化氮与肿瘤[J].医学综述,2007,13(9):667-669. 被引量:2
  • 4官成浓,冯冰,徐军发,潘达超,张英,马桂贤.原发性肝癌患者血清一氧化氮的测定及临床意义[J].实用全科医学,2007,5(7):571-572. 被引量:2
  • 5Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system [J].Nat Rev Immunol, 2009, 9: 162-174.
  • 6Li Q, Pan PY, Gu P, etal. Role of immature myeloid Gr-1+ cells in the development of antitumor immunity [J]. Cancer Res, 2004, 64: 1130-1139.
  • 7Kusmartsev S, Nefedova Y, Yoder D, et al. Antigen-specific inhibition of CD8+ T cells response by immature myeloid cells in cancer is mediated by reactive oxygen species [J]. J Immu- nol, 2004, 172: 989-999.
  • 8Bronte V, Apolloni E, Cabrelle A, et al. Identification of a CDIIb+/Gr-1+/CD31+ myeloid progenitor capable of activa- ting or suppressing CD8+ T cells [J]. Blood, 2000, 96: 3838-3846.
  • 9Nagaraj S, Youn JI, Gabrilovich DI. Reciprocal relationship between myeloid-derived suppressor cells and T cells[J].J Immunol, 2013, 191: 17-23.
  • 10Chan T, Wiltrout RH, Weiss JM. Immunotherapeutic modu- lation of the suppressive liver and tumor microenvironments [J]. Inter Immunopharmacul, 2011, 11: 879-889.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部